Anavex Life Sciences Corp (AVXL)

[Joseph_K]

This also supports my notion* that Anavex likely concluded the FDA will want a confirmatory trial that's larger and longer than the P2b/3. More expensive, of course, but if we're already selling blarcamesine for Alzheimer's under AA, it's fine with me. :)


*Third paragraph and after in https://investorshub.advfn.com/boards/read_msg.aspx?message_id=172005610